Given the tumor-promoting role of CD109 and of IL-6 in SCC and the recent findings that CD109 potentiates JAK/STAT3 signaling in lung adenocarcinoma and glioblastoma cells, it was important to establish whether CD109 regulates IL6Rα signaling in SCC and determine the mechanisms involved. The gene discussed is STAT3; the disease is neoplasm.